Greenvale Energy Proposes Director Share Placement to Fund Uranium Exploration at Thunderball Project

Greenvale Energy’s Strategic Focus on Uranium and the Thunderball Project

Greenvale Energy Ltd is an exploration company concentrating on uranium discovery and development within Australia. Its primary asset, the Thunderball Uranium Project, is located in the Northern Territory, a region historically significant for uranium mining. This location positions Greenvale at the forefront of renewed exploration interest driven by rising global energy demand and the transition toward cleaner energy sources.

By allocating proceeds from the proposed placement specifically to the Thunderball Project, Greenvale underscores its commitment to advancing exploration efforts in this jurisdiction. The Northern Territory has attracted substantial investor attention amid evolving nuclear energy markets. Concentrating capital on Thunderball aims to enhance geological knowledge and potentially expand the resource base within an area supported by established mining infrastructure and regulatory frameworks. The placement directly supports this strategic goal, with all proceeds earmarked for uranium exploration activities at Thunderball.

Details of the Director Placement Capital Structure

The capital raising consists of two components: ordinary fully paid shares and unlisted options. Greenvale plans to issue up to 3,030,303 ordinary shares at AUD 0.03300 each. These shares will be part of the existing class of securities, ranking equally with all previously issued ordinary shares from the date of issue. The pricing reflects the company’s current valuation and the cost at which directors will acquire equity stakes.

Additionally, 1,515,512 unlisted options will be issued on a free-attaching basis at one option for every two shares issued. These options, not listed on the ASX, have an exercise price of AUD 0.0700 per share and expire on 30 September 2028. This two-year exercise window provides an incentive aligning directors’ interests with shareholder value creation. If exercised, these options would convert into an additional 1,515,512 ordinary shares, subject to exercise before expiry.

Shareholder Approval and Compliance with ASX Listing Rules

In accordance with ASX Listing Rule 7.1, the proposed share and option issue requires shareholder approval prior to unconditional issuance. Greenvale has scheduled a shareholder meeting for 30 September 2026, which coincides with the proposed issue date. The company has not yet secured shareholder approval, and the date remains an estimate reflecting the proposal’s conditional status. Directors and management will provide shareholders with comprehensive information to facilitate an informed vote.

The approval request covers both the 3,030,303 shares and the 1,515,512 free-attaching options to directors, ensuring shareholder oversight of capital management and director participation. Upon approval, securities will be issued on 30 September 2026. Greenvale will also comply with Corporations Act secondary sale provisions by issuing a cleansing notice under relevant sections, enabling on-sale of securities within 12 months in line with legislation.

Valuation and Pricing Structure of the Placement

The AUD 0.03300 per share placement price sets a valuation benchmark reflecting current market conditions and investor appetite for Greenvale shares. This uniform pricing applies to both the shares and the underlying value of the attached options. The unlisted options’ exercise price of AUD 0.0700 is significantly higher, implying an expectation of share price appreciation over the two-year term.

This price differential incentivizes option holders to benefit from future capital gains. However, the company has not provided guidance on expected share price targets or the probability of options becoming in-the-money. Investors should be aware that option exercise depends on multiple factors including market conditions and company performance, with no guarantee of future share price increases.

Capital Deployment and Exploration Investment Strategy

Greenvale has confirmed that all proceeds from the placement will be exclusively allocated to uranium exploration at the Thunderball Uranium Project. This focus highlights management’s prioritization of exploration activities over other uses such as working capital or debt repayment. The funds will support drilling, geochemical analysis, and other programs aimed at advancing resource understanding.

The announcement does not specify exploration budgets, drilling targets, or timelines for expenditure. Investors should monitor forthcoming company updates and quarterly reports for operational details on capital utilization. This targeted capital deployment aligns with typical junior exploration company strategies, where advancing projects toward resource definition is key to value creation.

Director Participation and Governance Considerations

The placement involves issuance of securities to directors, constituting a related-party transaction under ASX Listing Rule 10.11. This necessitates enhanced disclosure and shareholder approval to ensure the transaction is conducted fairly and at arm’s length, protecting the interests of non-director shareholders.

Shareholder approval acts as a governance safeguard, allowing scrutiny of the terms and fairness of director participation. The company has not disclosed the identities of participating directors, their existing holdings, or reasons for limiting the placement to directors rather than other investors. Investors should consider potential dilution and alignment of director interests with broader shareholder value.

Settlement Timeline and Regulatory Compliance

The proposed issue date of 30 September 2026 sets the timeline for settlement and ASX quotation of the ordinary shares. Scheduling the shareholder meeting on the same day indicates an expedited process, with approval and issuance occurring concurrently. The company has not disclosed contingency plans if shareholder approval is delayed.

Post-issuance, ordinary shares will be quoted on ASX under code GRV and rank equally with existing shares regarding voting, dividends, and asset claims. The unlisted options will remain unquoted and recorded in the share registry. A cleansing notice will facilitate secondary sales within 12 months, allowing directors liquidity without triggering regulatory restrictions. No escrow or restricted securities arrangements have been indicated.

Financial Implications, Costs, and Market Considerations

The placement is reportedly underwritten and involves a lead manager or broker, though the company has not disclosed their identities, underwriting terms, or associated fees. Material costs are expected but remain unspecified. Detailed cost disclosures are anticipated in formal documentation or future announcements.

There is no indication of changes to Greenvale’s dividend policy as a result of the placement. This aligns with the typical approach of junior exploration companies, which generally reinvest earnings into project development rather than distributing dividends.

Risks Associated with Greenvale’s Exploration Model

As an exploration company, Greenvale’s value depends on successful project advancement and discovery of economically viable uranium resources. Exploration inherently carries uncertainty, with no assurance that activities at Thunderball will yield commercial mineralisation or economically extractable resources. Success depends on geology, permitting, commodity prices, and funding availability.

External factors such as uranium market dynamics, nuclear energy policies, export controls, and regulatory changes in the Northern Territory also impact project viability. The company has not disclosed permitting status or Indigenous engagement progress. Funding risk remains, contingent on capital market conditions and commodity cycles.

Investor Outlook and Upcoming Milestones

Investors should watch for the formal shareholder meeting notice and explanatory materials detailing placement terms and director interests. The 30 September 2026 meeting is a key event determining the capital raise’s progression. Post-approval, monitoring quarterly reports and project updates will be essential to assess exploration outcomes and strategic developments at Thunderball.

Market reaction to the placement and subsequent share price movements will offer insights into investor sentiment and valuation perceptions. Director exercise of unlisted options will serve as a barometer of confidence in the company’s growth prospects. Additionally, uranium market trends and regulatory developments in the Northern Territory will influence Greenvale’s exploration environment and shareholder value potential.